REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon AtomsHetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/11/07 - 20070010541 - Methods for treating vascular diseases The invention includes methods of treating or preventing vascular disease or promoting vascular growth or development. The methods can be used in the treatment of diseases associated with ischemia, such as heart attack and stroke. ... 11/02/06 - 20060247264 - Modulators of the glucocorticoid receptor and X, Y, n, R1—R25 are as described in the specification which are modulators of the glucocorticoid receptor and are thus useful for the treatment of animals requiring glucocorticoid receptor agonist therapy. Glucocorticoid receptor modulators are useful in the treatment of certain inflammatory conditions. ... 08/31/06 - 20060194825 - Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto Compounds which have utility in the treatment of conditions associated with altered mitochondrial function. The compounds having structure (I), including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as ... 07/06/06 - 20060148835 - Mglu receptors antagonists for treating disorders associated with mglu receptors including addiction and depression Methods are provided for treating disorders associated with mGlu receptors by simultaneously inhibiting at least two mGIuRs belonging to at least two different groups. In one embodiment, there are provided methods for treating a disorder associated with MGlu receptors 2, 3, and 5, including administering to a subject in need ... 05/04/06 - 20060094739 - 3-aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides along with compositions thereof, methods of use thereof (particularly as fungicides), and methods of making the same. ... 03/30/06 - 20060069111 - Compounds and methods for promoting smoking cessation Compounds and methods for promoting smoking cessation. The compounds may be used to treat a variety of other conditions and disease states. ... 03/16/06 - 20060058327 - Mitotic kinesin inhibitors The present invention relates to tetrahydropyridine compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals. ... 10/06/05 - 20050222187 - Use of benzoylalkyl-1,2,3,6-tetrahydropyridines a process for their preparation and the pharmaceutical compositions containing them. ... 08/18/05 - 20050182081 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents Benzocycloheptenes of formula (I), in which R1, R2 and Y have the meanings that indicated herein, exhibit selective estrogenic activity on bones and are suitable for the production of pharmaceutical agents, especially for prophylaxis and therapy of osteoporosis: ... 07/14/05 - 20050153996 - Compounds that modulate ppar activity and methods for their preparation This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing disipidemia, hypercholesteremia, obesity, eating disorders, hyperglycemia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia and diabetes ... 07/07/05 - 20050148614 - Combination of active ingredients for the treatment of senile dementia of the alzheimer type A pharmaceutical composition containing a compound (a) selected from 1-(2-naphth-2-ylethyl)-4-(3-trifluoro-methylphenyl)-1,2,3,6-tetrahydropryidine and a 4-substituted 1-phenylalkyl-1,2,3,6-tetrahydropyridine in combination with a compound (b) active in the symptomatic treatment of dementia of the Alzheimer type (DAT), especially an acetylcholinesterase inhibitor, for the complete treatment of DAT. ... 06/30/05 - 20050143406 - Amino-substituted hypocrellins for use as sonosensitizers The invention is novel amino-substituted hypocrellins, such as demethoxylated hypocrellin B, that are sonosensitizers, and their therapeutic use. ... 06/09/05 - 20050124642 - (1-indanone)-(1,2,3,6-tetrahydropyridine) compounds In the formula (I), R1, R2, R3 and R4 are the same as or different from each other. ... ### FreshPatents.com Support |